Records containing: Multiple Myeloma and Plasma Cell Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-06A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
-
CLINICAL_TRIALS study record update · 2025-10-27Tissue Procurement For Hematolymphoid Conditions
-
CLINICAL_TRIALS study record update · 2025-07-08Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
-
CLINICAL_TRIALS study record update · 2025-06-25Carolina Senior: UNC Registry for Older Cancer Patients
-
CLINICAL_TRIALS study record update · 2023-08-04A Randomized Phase II Dose Finding Study of Revlimid™ and Melphalan in Patients With Previously Untreated Multiple Myeloma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-06-22A Phase II Study of High-Dose Melphalan With Hematopoietic Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis
-
CLINICAL_TRIALS study record update · 2023-06-22A Phase II Trial Of Autologous Stem Cell Transplant Followed By Mini-Allogeneic Stem Cell Transplant In Lieu Of Standard Allogeneic Bone Marrow Transplantation For Treatment Of Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2023-06-18A Phase I Study of Amifostine Followed by High-Dose Escalation of Melphalan With Stem Cell Reconstitution for Patients With Primary Systemic Amyloidosis
-
CLINICAL_TRIALS study record update · 2023-06-15Phase II Study of Salvage Cellular Immunotherapy for Patients With Persistent or Recurrent Multiple Myeloma After Allogeneic Bone Marrow Transplantation From an HLA-Matched Sibling Donor
-
CLINICAL_TRIALS study record update · 2023-06-15A PHASE III STUDY OF PSC-833 IN COMBINATION WITH VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE (PSC-833/VAD) VERSUS VAD ALONE IN PATIENTS WITH RELAPSING OR REFRACTORY MULTIPLE MYELOMA
-
CLINICAL_TRIALS study record update · 2023-05-10A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Unrelated Donors in Patients With Advanced Hematologic Malignancies and Hematological Disorders
-
CLINICAL_TRIALS study record update · 2022-10-03A Phase II Study of VAD (Vincristine, Adriamycin, Dexamethasone) Plus Thalidomide (Low Dose) as Frontline Therapy for Newly Diagnosed Patients With Multiple Myeloma (MM)
-
CLINICAL_TRIALS study record update · 2022-07-05Dysregulation of Hematopoiesis in Fanconi Anemia
-
CLINICAL_TRIALS study record update · 2021-09-21Banking DNA for Analysis of Genetic Polymorphisms in Patients With Cancer
-
CLINICAL_TRIALS study record update · 2021-09-08A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
-
CLINICAL_TRIALS study record update · 2020-12-23A Randomised Phase II Clinical Trial Using Targeted Radiotherapy Delivered by an Yttrium-90 Radio-Labelled Anti-CD66 Monoclonal Antibody With High Dose Melphalan Compared to Melphalan Alone, Prior to Autologous Stem Cell Transplantation for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-12-09Unrelated or Partially Matched Allogeneic Donor Stem Cells for Lymphoma, Myeloma, and Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2020-10-06Phase II Study of Arsenic Trioxide in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-10-05CTI 1060: A Phase II Clinical Trial of Arsenic Trioxide and Dexamethasone as Therapy for Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-10-05A Randomized Phase III Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-09-17A Phase II Study of Maintenance Treatment With Sequential Bortezomib, Thalidomide and Dexamethasone Following Autologous Peripheral Blood Stem Cell Transplant in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-08-26Cellular Infusions in Patients With Recurrent or Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2020-08-03A Randomized, Open-Label, Multicenter Study Of Darbepoetin Alfa Administered Once Every Two Weeks (Q2W) Compared With rHuEPO Administered Once Every Week (QW) For The Treatment Of Anemia In Subjects With Non-Myeloid Malignancies Receiving Multiple Chemotherapy
-
CLINICAL_TRIALS study record update · 2020-08-03A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Fragmin (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients With Central Venous Catheters
-
CLINICAL_TRIALS study record update · 2020-07-27Preparatory Aid to Improve Decision Making About Cancer Clinical Trials (PRE-ACT)